Personalised Methadone Therapy
tm3128612257
Category of Technology / Product
- Description
- Intellectual Property
- Corporate Information
- Contact
No effective vaccine available to prevent HIV. The practice is low daily dose for fear of ADR's and variable pharmacology of CYP2B6,CYP2D6 and ??-opiate receptor gene. This causes high failure rates. Informed Methadone therapy with Pharmacogenetics and TDM. Customized pharmacogenetic testing combined with ELISA monitoring of methadone levels.Patients screened for genetic polymorphism of CYP2B6 and ??-opiate receptor. Dose of methadone determined based on polymorphism.Blood obtained for plasma methadone. Methadone dose adjusted. The results may improved compliance and retention and reduces risks for HIV.
Copyright
No
Industrial Design
No
Trademarks
No
Patent
No
Other IP Protection
No
Organization Name
Organization Category
Address
Institute of Research in Molecular Medicine (INFORMM), Universiti Sains Malaysia, Health Campus
16150 Kubang Kerian
Kelantan
Malaysia
Full Name [1]
Professor Rusli Ismail
Email [1]
isrusli@kb.usm.my
Share this page
